Technologies Pilot Funding

About the Fund

To promote novel methodological developments, the Translational Technologies & Resources (TTR) program pooled resources with the Emory Chemical Biology Discovery Center to establish the New Agent Development Fund. The goal is to promote the discovery of small molecules targeted to disease-related proteins for the development of novel therapeutic or diagnostic reagents.

Past Awardees

Xiaodong Cheng, PhD
Emory University, Department of Biochemistry
Project Title: Developing a new fluorescence-based assay for histone demethylation

Michelle LaPlaca, PhD
Georgia Tech, Department of Biomedical Engineering
Project Title: A New High-throughput Traumatic Neural Injury System

Ifor Williams, MD, PhD
Emory University, Department of Pathology
Project Title: High Throughput Screening for Small Molecule Inhibitors of CC Chemokine Receptor 6 (CCR6)

Xuebiao Yao, PhD
Morehouse School of Medicine, Department of Physiology
Project Title: Chemical Biological Study of BubR1 Signaling Pathway in Mitosis

How to Apply for Support

At this time, no request for applications (RFA) has been posted for this fund.